Live Help
Want to know more
Enter the details and we'll call you soon

Name :

Company Name :

City :

Mobile No. :

Email id :


Thank you for your details

Our Executive will reach you shortly.

Your Session Will Expire in   seconds.
If you do not wish to log-out, choose 'Let me continue'
Reset SessionCancel Session

Non-supply of products by co. on account of inability to produce NOC is an anti-competitive practice

June 6, 2019[2019] 106 40 (CCI)

COMPETITION LAW: Non-supply of pharmaceutical products by pharmaceutical companies to stockists on account of inability to produce NoC/LoC from State and regional chemists and druggist associations was anti-competitive in terms of section 3(1)

COMPETITION LAW: Where Commission deems fit that main investigation report is deficient qua certain aspects, Commission is well within its powers to send it to DG for further investigation before sharing investigation report with parties

COMPETITION LAW: Delineation of a relevant market is not a mandatory precondition for determination of violation of section 3

read more
Best view in 1140 x 768